Sage Therapeutics (SAGE) Ownership - Who owns Sage Therapeutics?

9 days until earnings call

Profile

Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
739.64M
P/E Ratio
N/A
Total Cash
717.01M
Projected Growth
N/A
Total Debt
3.31M
Revenue
91.06M
Risk (Beta)
0.28
Dividend Yield
N/A
Total Cash/Share
11.91
Total Debt/Equity
N/A
Revenue/Share
1.52 USD as % of share price

Fundamentals

SAGE
Capitalization
740M
P/E Ratio
N/A
Risk (Beta)
0.28
Dividend Yield
N/A
Total Cash
717M
Total Cash/Share
11.91
Total Debt
3.31M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.52%
Revenue
91.1M
ROE
N/A
Book Value
706M
P/B Ratio
1.05
Cash Flow
N/A
Earnings
-8.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
12.22
Current Revenue Per Employee
16225.87
Dividends Per Share - Security
N/A
EBITDA
-507.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.94
Revenue To Assets
-50.61
Shares Held By Institutions
2.47B
Shares Outstanding - Current
60.2M
Total Liabilities
61.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-43.286
View a ticker or compare two or three
SAGE
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com